46438-8
Cancer identification section Set NAACCR v.11
Active
21853-7 Sequence number central.patient Cancer
Term Description
Code indicates the sequence of all reportable neoplasms over the lifetime of the person. This data item differs from Sequence Number--Hospital [560], because the definitions of reportable neoplasms often vary between a hospital and a central registry. Each neoplasm is assigned a different number. Sequence Number 00 indicates that the person has had only one in situ or one malignant neoplasm as defined by the Federal reportable list (regardless of central registry reference date). Sequence Number 01 indicates the first of two or more reportable neoplasms, while 02 indicates the second of two or more reportable neoplasms, and so on. Because the time period of Sequence Number is a person's lifetime, reportable neoplasms not included in the central registry (those that occur outside the registry catchment area or before the reference date) also are allotted a sequence number. For example, a registry may contain a single record for a patient with a sequence number of 02 because the first reportable neoplasm preceded the central registry's reference date. Reporting Requirements: Federally Required and State/Province Defined The Federal or SEER/NPCR standard defining which neoplasms are reportable is described in Chapter III, Standards For Tumor Inclusion and Reportability. It is assumed that this shared standard is the "minimum" definition of reportability. Individual central cancer registries may define additional neoplasms as reportable. Numeric codes in the 00-35 range indicate the sequence of neoplasms of in situ or malignant behavior (2 or 3) at the time of diagnosis, which SEER/NPCR standards require to be reported. Codes 60 to 87 indicate the sequence of non-malignant tumors (as defined in Chapter III) and any other neoplasms that the central registry has defined as reportable. Neoplasms required by SEER/NPCR with an in situ or malignant behavior at the time of diagnosis are sequenced completely independently of this higher-numbered category. Sequence Number-Hospital does not affect Sequence Number-Central. The two notational systems are independent but central registries should take Sequence Number-Hospital [560] into account when coding Sequence Number Central. Timing Rule The sequence number may change over the lifetime of the patient. If an individual previously diagnosed with a single reportable malignant neoplasm is subsequently diagnosed with a second reportable malignant neoplasm, the sequence code for the first neoplasm changes from 00 to 01. A central registry might also discover that an individual with one or more known neoplasms had an earlier reportable neoplasm that had been unknown to the registry. Typically, a re-evaluation of all related sequence numbers is required whenever an additional neoplasm is identified. If two or more reportable neoplasms are diagnosed at the same time, the lowest sequence number is to be assigned to the diagnosis with the worst prognosis. If no difference in prognosis is evident, the decision is arbitrary. Timing rules for sequencing neoplasms coded in the 60-87 range are the same as timing rules for sequencing of required in situ or malignant neoplasms. If a registry collects any central registry-defined neoplasms, the codes 60-87 should be used. The codes 60-87 also should be used for non-malignant tumor diagnosed on or after January 1, 2004. Timing rules for sequencing these neoplasms are the same as timing rules for sequencing of required in situ or invasive neoplasms.
The purpose of sequencing based on the patient's lifetime is to truly identify the 00s, the people who only had one malignant primary in their lifetimes for survival analysis. If a central registry sequences by just what is reported to them, then it will be unclear whether 00 means the person only had one malignant primary in his lifetime or the person had one malignant primary since the central registry started collecting data. The Federally required reportable list has changed throughout the years, so the registry must use the appropriate reportable list for the year of diagnosis. The central registry reference date will not affect Sequence Number-Central... NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Sequence number central.patient
- Property
- Arb
- Time
- Pt
- System
- Cancer.XXX
- Scale
- Ord
- Method
Additional Names
- Short Name
- Seq # central.patient Cancer
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 1.0m
- Last Updated
- Version 2.32
Normative Answer List LL210-6
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| One primary only | 00 | LA4740-2 | |
| First of one or more primaries | 01 | LA3988-8 | |
| Second of two or more primaries | 02 | LA4311-2 | |
| Case of carcinoma in situ of the cervix diagnosed on January | 98 | LA4262-7 | |
| Unspecified sequence number | 99 | LA4449-0 |
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
| 59852-4 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-AR | Spanish (Argentina) | SEQUENCE NUMBER CENTRAL.PATIENT: |
| es-MX | Spanish (Mexico) | Número de secuencia central.paciente: |
| it-IT | Italian (Italy) | Numero di sequenza centrale.paziente: Synonyms: Arbitrario Cancro XXX Neoplasia maligna Punto nel tempo (episodio) Registro tumori |
| ru-RU | Russian (Russian Federation) | Порядковый номер центральный.пациент: Synonyms: Порядковый Произвольный Точка во времени; |
| zh-CN | Chinese (China) | 序号 中心.患者: Synonyms: NAACCR 肿瘤登记; |
21854-5 Date first Dx Cancer
Term Description
Date of initial diagnosis by a recognized medical practitioner for the tumor being reported whether clinically or microscopically confirmed. See page 81 for date format.
For more discussion on determining date of diagnosis, consult the SEER Program Manual or COC FORDS Manual... NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Date first Dx
- Property
- Date
- Time
- Pt
- System
- Cancer.XXX
- Scale
- Qn
- Method
Additional Names
- Short Name
- Date first Dx Cancer
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 1.0m
- Last Updated
- Version 2.50
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
| 59852-4 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
| 62949-3 | PhenX domain - Gastrointestinal |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Fecha primera Dx: |
| es-AR | Spanish (Argentina) | fecha del primer diagnóstico: |
| it-IT | Italian (Italy) | Data prima Dx: Synonyms: Cancro XXX Data prima diagnosi Neoplasia maligna Punto nel tempo (episodio) Registro tumori |
| ru-RU | Russian (Russian Federation) | Дата первый Dx: Synonyms: Количественный Точка во времени; |
| zh-CN | Chinese (China) | 初步诊断日期: Synonyms: Dx NAACCR 肿瘤登记; |
21855-2 Primary site Cancer
Term Description
Code for the primary site of the tumor being reported using either ICD-O-2 or ICD-O-3. NAACCR adopted ICD-O-2 as the standard coding system for tumors diagnosed beginning January 1, 1992. In addition, NAACCR recommended that tumors diagnosed prior to 1992 be converted to ICD-O-2. The topography (primary site) codes have not changed between ICD-O-2 and ICD-O-3... NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Primary site
- Property
- Anat
- Time
- Pt
- System
- Cancer.XXX
- Scale
- Nom
- Method
Additional Names
- Short Name
- Primary site Cancer
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 1.0m
- Last Updated
- Version 2.73
- Common Test Rank Get Info
- 16047
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
| 59852-4 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-AR | Spanish (Argentina) | localización primaria: |
| es-MX | Spanish (Mexico) | Sitio primario: |
| it-IT | Italian (Italy) | Sito principale: Synonyms: Anatomia Cancro XXX Neoplasia maligna Posto; |
| ru-RU | Russian (Russian Federation) | Основная локализация: Synonyms: Анатомия Номинальный; |
| zh-CN | Chinese (China) | 原发部位: Synonyms: NAACCR 肿瘤登记; |
21856-0 Histology ICD-O-2 Cancer
Term Description
Codes for the histologic type of the tumor being reported using ICD-O-2. NAACCR adopted ICD-O-2 as the standard coding system for tumors diagnosed in 1992 and later and recommended that prior cases be converted to ICD-O-2.
Note: See Histology (73-91) ICD-O-1 [1971] for ICD-0-1 and field trial codes... NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Histology ICD-O-2
- Property
- Prid
- Time
- Pt
- System
- Cancer.XXX
- Scale
- Nom
- Method
Additional Names
- Short Name
- Histology ICD-O-2 Cancer
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 1.0m
- Last Updated
- Version 2.27
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
| 59852-4 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-AR | Spanish (Argentina) | HISTOLOGY ICD-O-2: |
| es-MX | Spanish (Mexico) | Histología ICD-O-2: |
| it-IT | Italian (Italy) | Istologia ICD-O-2: Synonyms: Cancro XXX Neoplasia maligna Presenza o Identità Punto nel tempo (episodio) Registro tumori |
| ru-RU | Russian (Russian Federation) | Гистология МКБ-О-2: Synonyms: Номинальный; |
| zh-CN | Chinese (China) | 组织学 ICD-O-2: Synonyms: Ⅱ ICD ICD-O ICD-O-2 国际肿瘤学分类; |
21857-8 Behavior ICD-O-2 Cancer
Term Description
Code for the behavior of the tumor being reported using ICD-O-2. NAACCR adopted ICD-O-2 as the standard coding system for tumors diagnosed from January 1, 1992, through December 31, 2000. In addition, NAACCR recommended that cases diagnosed prior to 1992 be converted to ICD-O-2. See Behavior (73-91) ICD-O-1 [1972], for ICD-O-1 and field trial codes... NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Behavior ICD-O-2
- Property
- Prid
- Time
- Pt
- System
- Cancer.XXX
- Scale
- Nom
- Method
Additional Names
- Short Name
- Behavior ICD-O-2 Cancer
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 1.0m
- Last Updated
- Version 2.32
Normative Answer List LL212-2
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Grade I | 1 | LA3967-2 | |
| Grade II | 2 | LA3992-0 | |
| Grade III | 3 | LA4027-4 | |
| Grade IV | 4 | LA3982-1 | |
| T-cell | 5 | LA4470-6 | |
| B-cell | 6 | LA4275-9 | |
| Null cell | 7 | LA4748-5 | |
| NK (natural killer) cell | 8 | LA4573-7 | |
| Grade/differentiation unknown, not stated, or not applicable | 9 | LA3983-9 |
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
| 59852-4 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-AR | Spanish (Argentina) | comportamiento CIE-O-2: |
| es-MX | Spanish (Mexico) | Comportamiento ICD-O-2: |
| it-IT | Italian (Italy) | Comportamento ICD-O-2: Synonyms: Cancro XXX Neoplasia maligna Presenza o Identità Punto nel tempo (episodio) Registro tumori |
| ru-RU | Russian (Russian Federation) | Поведение ICD-O-2: Synonyms: Номинальный; |
| zh-CN | Chinese (China) | 行为 ICD-O-2: Synonyms: Ⅱ ICD ICD-O ICD-O-2 国际肿瘤学分类; |
31205-8 Histology ICD-O-3 Cancer
Term Description
Codes for the histologic type of the tumor being reported using ICD-O-3. NAACCR adopted ICD-O-3 as the standard coding system for tumors diagnosed in 2001 and later, and recommended that prior tumors be converted from ICD-O-2.
Note: See Histology (92-00) ICD-O-2 [420] for ICD-O-2 codes... NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Histology ICD-O-3
- Property
- Prid
- Time
- Pt
- System
- Cancer.XXX
- Scale
- Nom
- Method
Additional Names
- Short Name
- Histology ICD-O-3 Cancer
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 2.07
- Last Updated
- Version 2.27
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
| 59852-4 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
| 77753-2 | Tumor morphology panel Cancer |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-AR | Spanish (Argentina) | HISTOLOGY ICD-O-3: |
| es-MX | Spanish (Mexico) | Histología ICD-O-3: |
| it-IT | Italian (Italy) | Istologia ICD-O-3: Synonyms: Cancro XXX Neoplasia maligna Presenza o Identità Punto nel tempo (episodio) Registro tumori |
| ru-RU | Russian (Russian Federation) | Гистология МКБ-О-3: Synonyms: Номинальный; |
| zh-CN | Chinese (China) | 组织学 ICD-O-3: Synonyms: Ⅲ ICD ICD-O ICD-O-3 国际肿瘤学分类; |
31206-6 Behavior ICD-O-3 Cancer
Term Description
Code for the behavior of the tumor being reported using ICD-O-3. NAACCR adopted ICD-O-3 as the standard coding system for tumors diagnosed beginning January 1, 2001, and later recommended that prior cases be converted from ICD-O-2. See Behavior (92-00) ICD-O-2 [430], for ICD-O-2 codes.
Juvenile astrocytoma is coded as borderline in ICD-O-3, North American registries report as 9421/3... NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Behavior ICD-O-3
- Property
- Prid
- Time
- Pt
- System
- Cancer.XXX
- Scale
- Nom
- Method
Additional Names
- Short Name
- Behavior ICD-O-3 Cancer
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 2.07
- Last Updated
- Version 2.73
- Common Test Rank Get Info
- 11113
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
| 59852-4 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
| 77753-2 | Tumor morphology panel Cancer |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-AR | Spanish (Argentina) | comportamiento CIE-O-3: |
| es-MX | Spanish (Mexico) | Comportamiento ICD-O-3: |
| it-IT | Italian (Italy) | Comportamento ICD-O-3: Synonyms: Cancro XXX Neoplasia maligna Presenza o Identità Punto nel tempo (episodio) Registro tumori |
| ru-RU | Russian (Russian Federation) | Поведение ICD-O-3: Synonyms: Номинальный; |
| zh-CN | Chinese (China) | 行为 ICD-O-3: Synonyms: Ⅲ ICD ICD-O ICD-O-3 国际肿瘤学分类; |
21858-6 Grade Cancer
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Grade
- Property
- Prid
- Time
- Pt
- System
- Cancer.XXX
- Scale
- Nom
- Method
Additional Names
- Short Name
- Grade Cancer
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 1.0m
- Last Updated
- Version 2.73
- Common Test Rank Get Info
- 11224
Normative Answer List LL213-0
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Code - not defined in code system | 0 | LA4158-7 | |
| Grade I | 1 | LA3967-2 | |
| Grade II | 2 | LA3992-0 | |
| Grade III | 3 | LA4027-4 | |
| Grade IV | 4 | LA3982-1 | |
| T-cell | 5 | LA4470-6 | |
| B-cell | 6 | LA4275-9 | |
| Null cell | 7 | LA4748-5 | |
| NK (natural killer) cell | 8 | LA4573-7 | |
| Grade/differentiation unknown, not stated, or not applicable | 9 | LA3983-9 |
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
| 59852-4 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
| 77753-2 | Tumor morphology panel Cancer |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-AR | Spanish (Argentina) | grado: |
| es-ES | Spanish (Spain) | Grado: |
| es-MX | Spanish (Mexico) | Calificación: |
| it-IT | Italian (Italy) | Grado: Synonyms: Cancro XXX Neoplasia maligna Presenza o Identità Punto nel tempo (episodio) Registro tumori |
| ru-RU | Russian (Russian Federation) | Стадия: Synonyms: Номинальный; |
| zh-CN | Chinese (China) | 等级: Synonyms: NAACCR 肿瘤登记; |
42129-7 Site coding system.current Cancer site
Term Description
Code that best describes how the primary site currently is coded. If converted, this field shows the system to which it is converted... NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Site coding system.current
- Property
- Type
- Time
- Pt
- System
- Cancer.XXX.anatomic site
- Scale
- Nom
- Method
Additional Names
- Short Name
- Site coding system.current Cancer site
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 2.16
- Last Updated
- Version 2.29
Normative Answer List LL214-8
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| ICD-8 | 1 | LA3913-6 | |
| ICD-9 | 2 | LA3926-8 | |
| ICD-0 1st Ed. | 3 | LA4008-4 | |
| ICD-0 2nd Ed. | 4 | LA4009-2 | |
| ICD-O, Third Edition | 5 | LA3951-6 | |
| ICD-10 | 6 | LA4012-6 | |
| Other | 9 | LA46-8 |
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
| 59852-4 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Sistema de codificación del sitio actual: |
| it-IT | Italian (Italy) | Sito, sistema di codifica.corrente: Synonyms: Cancro XXX Neoplasia maligna Posto; |
| ru-RU | Russian (Russian Federation) | Локализация кодирование система.текущий: Synonyms: Номинальный; |
| zh-CN | Chinese (China) | 部位编码系统.现行: Synonyms: NAACCR 肿瘤登记; |
21859-4 Coding system.original Cancer site
Term Description
Code that best describes how primary site was originally coded. If converted, this field shows the original coding system used... NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Coding system.original
- Property
- Type
- Time
- Pt
- System
- Cancer.XXX.anatomic site
- Scale
- Nom
- Method
Additional Names
- Short Name
- Coding sys.original Cancer site
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 1.0m
- Last Updated
- Version 2.29
Normative Answer List LL214-8
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| ICD-8 | 1 | LA3913-6 | |
| ICD-9 | 2 | LA3926-8 | |
| ICD-0 1st Ed. | 3 | LA4008-4 | |
| ICD-0 2nd Ed. | 4 | LA4009-2 | |
| ICD-O, Third Edition | 5 | LA3951-6 | |
| ICD-10 | 6 | LA4012-6 | |
| Other | 9 | LA46-8 |
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
| 59852-4 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-AR | Spanish (Argentina) | sistema de codificación.original: |
| es-MX | Spanish (Mexico) | Sistema de codificación original: |
| it-IT | Italian (Italy) | Sistema di codifica.originale: Synonyms: Cancro XXX Neoplasia maligna Punto nel tempo (episodio) Registro tumori Sito anatomico di neoplasia maligna XXX |
| ru-RU | Russian (Russian Federation) | Кодирование система.первоначальная: Synonyms: Кодирование система.исходная Номинальный; |
| zh-CN | Chinese (China) | 编码系统.原始: Synonyms: NAACCR 肿瘤登记; |
42034-9 Coding system.current Cancer morphology
Term Description
Code that best describes how primary site was originally coded. If converted, this field shows the original coding system used... NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Coding system.current
- Property
- Type
- Time
- Pt
- System
- Cancer.XXX.morphology
- Scale
- Nom
- Method
Additional Names
- Short Name
- Coding sys.current Cancer morph
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 2.16
- Last Updated
- Version 2.29
Normative Answer List LL216-3
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| ICD-0 1st Ed. | 1 | LA4008-4 | |
| ICD-0 1986 Field Trial | 2 | LA3998-7 | |
| ICD-0 1988 Field Trial | 3 | LA4007-6 | |
| ICD-0 2nd Ed. | 4 | LA4009-2 | |
| ICD-0 2nd Ed.+ 1995 mods | 5 | LA4010-0 | |
| ICD-0 2nd Ed.+ 1998 mods | 6 | LA4011-8 | |
| ICD-O-3 | 7 | LA3958-1 | |
| Other | 9 | LA46-8 |
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
| 59852-4 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Sistema de codificación actual: |
| it-IT | Italian (Italy) | Sistema di codifica.corrente: Synonyms: Cancro XXX Morfologia di neoplasia maligna XXX Neoplasia maligna Punto nel tempo (episodio) Registro tumori |
| ru-RU | Russian (Russian Federation) | Кодирование система.текущий: Synonyms: Номинальный; |
| zh-CN | Chinese (China) | 编码系统.现行: Synonyms: NAACCR 肿瘤登记; |
21860-2 Coding system.original Cancer morphology
Term Description
Code that best describes how morphology was originally coded. If later converted, this field shows the original codes used... NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Coding system.original
- Property
- Type
- Time
- Pt
- System
- Cancer.XXX.morphology
- Scale
- Nom
- Method
Additional Names
- Short Name
- Coding sys.original Cancer morph
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 1.0m
- Last Updated
- Version 2.29
Normative Answer List LL216-3
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| ICD-0 1st Ed. | 1 | LA4008-4 | |
| ICD-0 1986 Field Trial | 2 | LA3998-7 | |
| ICD-0 1988 Field Trial | 3 | LA4007-6 | |
| ICD-0 2nd Ed. | 4 | LA4009-2 | |
| ICD-0 2nd Ed.+ 1995 mods | 5 | LA4010-0 | |
| ICD-0 2nd Ed.+ 1998 mods | 6 | LA4011-8 | |
| ICD-O-3 | 7 | LA3958-1 | |
| Other | 9 | LA46-8 |
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
| 59852-4 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-AR | Spanish (Argentina) | sistema de codificación.original: |
| es-MX | Spanish (Mexico) | Sistema de codificación original: |
| it-IT | Italian (Italy) | Sistema di codifica.originale: Synonyms: Cancro XXX Morfologia di neoplasia maligna XXX Neoplasia maligna Punto nel tempo (episodio) Registro tumori |
| ru-RU | Russian (Russian Federation) | Кодирование система.первоначальная: Synonyms: Кодирование система.исходная Номинальный; |
| zh-CN | Chinese (China) | 编码系统.原始: Synonyms: NAACCR 肿瘤登记; |
21861-0 Dx confirmed by Cancer
Term Description
Code for the best method of diagnostic confirmation of the cancer being reported at any time in the patient's history
Diagnostic confirmation is useful to calculate rates based on microscopically confirmed cancers. Full incidence calculations must also include tumors that are only confirmed clinically. The percentage of tumors that are clinically diagnosed only is an indication of whether case finding is including sources outside of pathology reports... NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Dx confirmed by
- Property
- Type
- Time
- Pt
- System
- Cancer.XXX
- Scale
- Nom
- Method
Additional Names
- Short Name
- Dx confirmed by Cancer
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 1.0m
- Last Updated
- Version 2.29
Normative Answer List LL218-9
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Positive Histology | 1 | LA4674-3 | |
| Positive Cytology | 2 | LA4675-0 | |
| Micro Confirmation, NOS | 4 | LA4610-7 | |
| Positive Lab/Marker Study | 5 | LA4673-5 | |
| Direct Visualization | 6 | LA4199-1 | |
| Radiography/Imaging Only | 7 | LA4383-1 | |
| Clinical Dx Only | 8 | LA4163-7 | |
| Unknown Copyright http://snomed.info/sct ID:261665006 Unknown (qualifier value) | 9 | LA4489-6 |
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
| 59852-4 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-AR | Spanish (Argentina) | diagnóstico confirmado por: |
| es-MX | Spanish (Mexico) | Dx confirmado por: |
| it-IT | Italian (Italy) | Dx confermata da: Synonyms: Cancro XXX Diagnosi confermata da Neoplasia maligna Punto nel tempo (episodio) Registro tumori |
| ru-RU | Russian (Russian Federation) | Dx подтверждён: Synonyms: Номинальный; |
| zh-CN | Chinese (China) | 诊断确认者: Synonyms: Dx NAACCR 肿瘤登记; |
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
21862-8 Source of document used to abstract Cancer
Term Description
This variable codes the source documents used to abstract the majority of information on the tumor being reported. This may not be the source of original case finding (for example, if a case is identified through a pathology laboratory report review and all source documents used to abstract the case are from the physician's office, code this item 4).
The code in this field can be used to explain why information may be incomplete on a tumor. For example, death certificate only cases have unknown values for many data items, so one may want to exclude them from some analyses. The field also is used to monitor the success of non-hospital case reporting and follow-back mechanisms. All population-based registries should have some death certificate-only cases where no hospital admission was involved, but too high a percentage can imply both shortcomings in case-finding and that follow-back to uncover missed hospital reports was not complete. Coding Instructions Code in the following priority order: 1, 2, 8, 4, 3, 5, 6, 7. This is a change to reflect the addition of codes 2 and 8 and to prioritize laboratory reports over nursing home reports. The source facilities included in the previous code 1 (hospital inpatient and outpatient) are split between codes 1, 2, and 8. This data item is intended to indicate the completeness of information available to the abstractor. Reports from health plans (e.g., Kaiser, Veterans Administration, military facilities) in which all diagnostic and treatment information is maintained centrally and is available to the abstractor are expected to be at least as complete as reports for hospital inpatients, which is why these sources are grouped with inpatients and given the code with the highest priority. Sources coded with '2' usually have complete information on the cancer diagnosis, staging, and treatment. Sources coded with '8' would include, but would not be limited to, outpatient surgery and nuclear medicine services. A physician's office that calls itself a surgery center should be coded as a physician's office. Surgery centers are equipped and staffed to perform surgical procedures under general anesthesia. If a physician's office calls itself a surgery center, but cannot perform surgical procedures under general anesthesia, code as a physician office... NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Source of document used to abstract
- Property
- Type
- Time
- Pt
- System
- Cancer.XXX
- Scale
- Nom
- Method
Additional Names
- Short Name
- Source doc used to abstract Cancer
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 1.0m
- Last Updated
- Version 2.29
Normative Answer List LL220-5
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Hospital or Clinic | 1 | LA4005-0 | |
| Laboratory Only | 3 | LA4587-7 | |
| Physician's Office | 4 | LA4685-9 | |
| Nursing/Conv home/Hospice | 5 | LA4746-9 | |
| Autopsy Only | 6 | LA4222-1 | |
| Death Certificate Only | 7 | LA4197-5 |
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
| 59852-4 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-AR | Spanish (Argentina) | fuente de documento utilizado para el resumen: |
| es-MX | Spanish (Mexico) | Fuente del documento utilizado para resumir: |
| it-IT | Italian (Italy) | Fonte di documento usato per estrarre informazioni: Synonyms: Cancro XXX Neoplasia maligna Punto nel tempo (episodio) Registro tumori |
| ru-RU | Russian (Russian Federation) | Источник документа, использованного для извлечения: Synonyms: Номинальный; |
| zh-CN | Chinese (China) | 用于概括的文档来源: Synonyms: NAACCR 肿瘤登记; |
21863-6 Date last screened Cancer
Term Description
Most recent date on which the patient participated in a screening program related to this primary cancer. See page 81 for date format... NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Date last screened
- Property
- Date
- Time
- Pt
- System
- Cancer.XXX
- Scale
- Qn
- Method
Additional Names
- Short Name
- Date last screened Cancer
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 1.0m
- Last Updated
- Version 2.50
Normative Answer List LL221-3
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Patient participated in screening program related to this pr | 99999999 | LA4638-8 | |
| Patient did not participate in screening program related to | 00000000 | LA4646-1 |
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-AR | Spanish (Argentina) | LAST.SCREENED FOR: |
| es-MX | Spanish (Mexico) | Fecha de la última revisión: |
| it-IT | Italian (Italy) | Data ultimo controllo: Synonyms: Cancro XXX Neoplasia maligna Punto nel tempo (episodio) Registro tumori |
| ru-RU | Russian (Russian Federation) | Дата последний скрин: Synonyms: Количественный Точка во времени; |
| zh-CN | Chinese (China) | 末次筛查日期: Synonyms: NAACCR 肿瘤登记; |
21864-4 Most recent screening result for Cancer
Term Description
Code the findings from screening recorded in Screening Date [510]... NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Most recent screening result for
- Property
- Type
- Time
- Pt
- System
- Cancer.XXX
- Scale
- Nom
- Method
Additional Names
- Short Name
- Most recent screening result for Cancer
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 1.0m
- Last Updated
- Version 2.29
Normative Answer List LL222-1
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Within Normal Limits | 0 | LA4439-1 | |
| Abnormal/not suggest Ca | 1 | LA4239-5 | |
| Abnormal/suggest Ca | 2 | LA4240-3 | |
| Equivocal/no follow-up req | 3 | LA4019-1 | |
| Equivocal/eval recommend | 4 | LA4020-9 | |
| Not applicable | 8 | LA4720-4 | |
| Unknown Copyright http://snomed.info/sct ID:261665006 Unknown (qualifier value) | 9 | LA4489-6 |
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-AR | Spanish (Argentina) | MOST RECENT SCREENING RESULT FOR: |
| es-MX | Spanish (Mexico) | Resultado de cribado más reciente para: |
| it-IT | Italian (Italy) | Risultati screening più recente per: Synonyms: Cancro XXX Neoplasia maligna Punto nel tempo (episodio) Registro tumori |
| ru-RU | Russian (Russian Federation) | Наиболее свежий скрининг результат: Synonyms: Номинальный; |
| zh-CN | Chinese (China) | 最近筛查结果: Synonyms: Asympt NAACCR 肿瘤登记; |
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
42035-6 Casefinding source Cancer
Term Description
This variable codes the earliest source of identifying information. For cases identified by a source other than reporting facilities (such as through death clearance or as a result of an audit), this variable codes the type of source through which the tumor was first identified. This data item cannot be used by itself as a data quality indicator. The timing of the casefinding processes (e.g., death linkage) varies from registry to registry, and the coded value of this variable is a function of that timing.
This data item will help reporting facilities as well as regional and central registries in prioritizing their casefinding activities. It will identify reportable tumors that were first found through death clearance or sources other than traditional reporting facilities. It provides more detail than "Type of Reporting Source."
Coding Instructions This variable is intended to code the source that first identified the tumor. Determine where the case was first identified and enter the appropriate code. At the regional or central level, if a hospital and a non-hospital source identified the case independently of each other, enter the code for the non-hospital source (i.e., codes 30-95 have priority over codes 10-29). If the case was first identified at a reporting facility (codes 10-29), code the earliest source (based on patient or specimen contact at the facility) of identifying information.
If a death certificate, independent pathology laboratory report, consultation-only report from a hospital, or other report was used to identify a case that was then abstracted from a different source, enter the code for the source that first identified the case, not the source from which it was subsequently abstracted. If a regional or central registry identifies a case and asks a reporting facility to abstract it, enter the code that corresponds to the initial source, not the code that corresponds to the eventual reporting facility.
.. NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Casefinding source
- Property
- Prid
- Time
- Pt
- System
- Cancer.XXX
- Scale
- Nom
- Method
Additional Names
- Short Name
- Casefinding source Cancer
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 2.16
- Last Updated
- Version 2.32
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
| 59852-4 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Fuente de búsqueda de casos: |
| it-IT | Italian (Italy) | Struttura originaria di identificazione del caso: Synonyms: Cancro XXX Neoplasia maligna Presenza o Identità Punto nel tempo (episodio) Registro tumori |
| ru-RU | Russian (Russian Federation) | Случай обнаружение источник: Synonyms: Номинальный; |
| zh-CN | Chinese (China) | 案例查找来源: Synonyms: NAACCR 肿瘤登记; |
42028-1 NAACCR ambiguous terminology as basis for diagnosis
Term Description
Identifies cases for which an ambiguous term is the most definitive word or phrase used to establish a cancer diagnosis (i.e., to determine whether or not the case is reportable). Do not include cases where a definite statement of malignancy is made within two months following the original/initial diagnosis. (This does not include the use of ambiguous terminology from cancer screening followed by a positive cancer confirmation that is follow-up to the screening.)
Cases include reportable cancer diagnoses (by any method including death certificate only and autopsy only) based only on ambiguous terminology. There is no conclusive diagnosis (positive clinical diagnosis, pathology, etc.) within two months of the original diagnosis that will further qualify the ambiguous term (no longer based on ambiguous terminology).
Ambiguous terminology may originate from any source document, such as pathology report, radiology report, or from a clinical report.
This data item is used only when ambiguous terminology is used to establish diagnosis. It is not used when ambiguous terminology is used to clarify a primary site, specific histology, histologic group, or stage of disease.
Ambiguous terms that are reportable
Apparent(ly)
Appears (effective with cases diagnosed 1/1/1998 and later)
Comparable with (effective with cases diagnosed 1/1/1998 and later)
Compatible with (effective with cases diagnosed 1/1/1998 and later)
Consistent with
Favor(s)
Malignant appearing (effective with cases diagnosed 1/1/1998 and later)
Most likely
Presumed
Probable
Suspect(ed)
Suspicious (for)
Typical (of)
Follow-back to a physician or subsequent readmission (following the initial two month diagnosis period) may eventually confirm a cancer diagnosis (conclusive cancer diagnosis greater than two months after date of initial diagnosis that was based on ambiguous terminology).
These cases should be excluded from case selection in research studies and from annual contact (i.e., follow-up) by registrars. Direct patient contact is not recommended for these cases.
Cases with a reportable cancer diagnosis that has been established based only on reports that contain ambiguous terminology to describe final diagnostic findings cannot currently be identified.
Multiple surveys have identified a lack of consensus in the interpretation and use of ambiguous terms across physician specialties. These cases may or may not have an actual cancer diagnosis based on clinician, radiologist, and pathologist review.
Furthermore, the historical interpretation and use of ambiguous terms by cancer registrars and registries has not been consistent or compatible with physician use of these terms.
This data item will identify specific primary sites where the ambiguous terminology is commonly used to describe or establish a cancer diagnosis.
Data collected will be used as the basis for modifications to case inclusion and reportable rules following complete analysis and impact assessment.
This data item will allow cases to be identified within an analysis file. It will also allow these cases to be identified and excluded from patient contact studies.
.. NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- NAACCR ambiguous terminology as basis for diagnosis
- Property
- Prid
- Time
- Pt
- System
- Cancer.XXX
- Scale
- Nom
- Method
Additional Names
- Short Name
- NAACCR Ambiguous Terminology Dx Cancer
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 2.16
- Last Updated
- Version 2.32
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
| 59852-4 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Terminología ambigua de NAACCR como base para el diagnóstico: |
| it-IT | Italian (Italy) | NAACCR, terminologia ambigua come base per diagnosi: Synonyms: Cancro XXX Neoplasia maligna Presenza o Identità Punto nel tempo (episodio) Registro tumori |
| ru-RU | Russian (Russian Federation) | NAACCR двусмысленная терминология в основе диагноза: Synonyms: Номинальный; |
| zh-CN | Chinese (China) | 作为诊断基础的 NAACCR 歧义术语: Synonyms: NAACCR 肿瘤登记; |
42029-9 Date of conclusive diagnosis Cancer
Term Description
Documents the date when a conclusive cancer diagnosis (definite statement of malignancy) is made following an initial diagnosis that was based only on ambiguous terminology. The date of the conclusive diagnosis must be greater than two months following the initial (ambiguous terminology only) diagnosis. See page 81 for date format.
If the date of conclusive diagnosis is within two months following the initial (ambiguous terminology only) diagnosis, the case does not meet the criteria for ambiguous terminology only.
This date will allow analysis of the primary site locations and frequency of cases that were originally diagnosed by ambiguous terminology and later confirmed by other conclusive method.
This date will also allow for analysis of the time interval between cancer diagnosis based on ambiguous terminology and confirmation of the cancer diagnosis by conclusive means.
The date must be greater than two months from the original/initial diagnosis date.
.. NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Date of conclusive diagnosis
- Property
- TmStp
- Time
- Pt
- System
- Cancer.XXX
- Scale
- Qn
- Method
Additional Names
- Short Name
- Date of conclusive Dx Cancer
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 2.16
- Last Updated
- Version 2.27
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
| 59852-4 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Fecha de diagnóstico concluyente: |
| it-IT | Italian (Italy) | Data di diagnosi conclusiva: Synonyms: Cancro XXX Neoplasia maligna Punto nel tempo (episodio) Registro tumori Time stamp (Data e Ora) |
| ru-RU | Russian (Russian Federation) | Дата подтверждённый диагноз: Synonyms: Time Stamp (Дата и Время) Количественный Точка во времени; |
| zh-CN | Chinese (China) | 结论性诊断日期: Synonyms: NAACCR 肿瘤登记; |
42030-7 Multiple tumors reported as single primary Cancer
Term Description
This data item is used to identify cases with multiple tumors that are abstracted and reported as a single primary using the SEER, IARC, or Canadian Cancer Registry multiple primary rules. Multiple tumors may individually exhibit in situ, invasive, or any combination of in situ and invasive behaviors. Multiple intracranial and central nervous system tumors may individually exhibit benign, borderline, malignant, or any combination of these behaviors. Multiple tumors found in the same organ or in a single primary site may occur at the time of initial diagnosis or within one year of the initial diagnosis.
The data item does not apply to metastatic tumors.
Data will be collected at the time of initial case abstract or within one year of the initial diagnosis.
This data item is also used when a physician states that there are two or more primaries, but for surveillance purposes, the case is reported as a single primary.
Patients with multiple tumors that are currently reported as a single primary for surveillance purposes may have a worse prognosis or more extensive treatment than patients with a single tumor. This data item will make it possible to identify important information about these cases for data analysis.
Data collected under this item will be used to assess the number, type, and anatomic location of multiple tumors currently abstracted as a single primary using the SEER, IARC, or Canadian Cancer Registry rules for determining multiple primary cancers and the impact of these cases on cancer case counts and incidence rates.
Data will also serve as a basis for measuring the impact and feasibility of future modifications to the multiple primary rules.
This data item will make it possible to compare individually reported cancer cases with historical data if the rules are changed.
.. NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Multiple tumors reported as single primary
- Property
- Prid
- Time
- Pt
- System
- Cancer.XXX
- Scale
- Nom
- Method
Additional Names
- Short Name
- Mult Tum Rpt as One Prim Cancer
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 2.16
- Last Updated
- Version 2.32
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
| 59852-4 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Múltiples tumores informados como primarios únicos: |
| it-IT | Italian (Italy) | Tumori multipli riportati come primario singolo: Synonyms: Cancro XXX Neoplasia maligna Presenza o Identità Punto nel tempo (episodio) Registro tumori |
| ru-RU | Russian (Russian Federation) | Множественные опухоли сообщены как единичная первичная: Synonyms: Номинальный; |
| zh-CN | Chinese (China) | 报告为单一原发的多发性肿瘤: Synonyms: NAACCR 肿瘤登记; |
42031-5 Date of diagnosis of multiple tumors Cancer
Term Description
This data item is used to identify the month, day and year the patient is diagnosed with multiple or subsequent reportable tumor(s) reported as a single primary using the SEER, IARC, or Canadian Cancer Registry multiple primary rules. Multiple tumors must have the same histology as the original tumor and must be located in the same organ or primary site as the original tumor, using primary site and histology coding rules. See page 81 for date format.
Record the Date of Diagnosis as the Date of Multiple Tumors when multiple reportable tumors are abstracted and reported as a single primary at the time of initial diagnosis.
Record the date the first subsequent reportable tumor was diagnosed (same histology and same site as the original tumor, using the primary site and histology coding rules).
The Date of Multiple Tumors must occur within one year following the initial/first diagnosis of the reported tumor.
Patients with multiple tumors currently reported as a single primary for surveillance purposes may have a worse prognosis or more extensive treatment than patients with a single tumor. This data item will make it possible to identify important information about these cases for data analysis.
The Date of Multiple Tumors will allow separation of cases with multiple reportable tumors present at the time of initial diagnosis from cases with subsequent reportable tumors. The date will allow tracking of the time interval between the date of original diagnosis and the first date of subsequent tumor(s) for specific primary sites and tumor histologies.
.. NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Date of diagnosis of multiple tumors
- Property
- TmStp
- Time
- Pt
- System
- Cancer.XXX
- Scale
- Qn
- Method
Additional Names
- Short Name
- Date Dx multiple tumors Cancer
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 2.16
- Last Updated
- Version 2.32
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
| 59852-4 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Fecha de diagnóstico de tumores múltiples: |
| it-IT | Italian (Italy) | Data di diagnosi di tumori multipli: Synonyms: Cancro XXX Neoplasia maligna Punto nel tempo (episodio) Registro tumori Time stamp (Data e Ora) |
| ru-RU | Russian (Russian Federation) | Дата диагноз множественной опухоли: Synonyms: Time Stamp (Дата и Время) Количественный Точка во времени; |
| zh-CN | Chinese (China) | 多发肿瘤诊断日期: Synonyms: NAACCR 肿瘤登记; |
42032-3 Number of tumors at diagnosis Cancer
Term Description
This data item is used to count the number of individual reportable tumors (multiplicity) that are present at the time of diagnosis or the number of reportable tumors that occur within one year of the original diagnosis reported as a single primary using the SEER, IARC, or Canadian Cancer Registry multiple primary rules.
Patients with multiple tumors currently reported as a single primary for surveillance purposes may have a worse prognosis or more extensive treatment than patients with a single tumor. This data item will make it possible to identify important information about these cases for data analysis.
Data collected under this item will be used to assess the number, type, and anatomic location of multiple reportable tumors currently abstracted as a single primary using the SEER, IARC, or Canadian Cancer Registry rules for determining multiple primary cancers and the impact of these cases on cancer case counts and incidence rates.
Data will also serve as a basis for measuring the impact and feasibility of future modifications to the multiple primary rules.
This data item will also make it possible to compare individually reported cancer cases with historical data if the rules are changed.
.. NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Number of tumors at diagnosis
- Property
- Num
- Time
- Pt
- System
- Cancer.XXX
- Scale
- Qn
- Method
Additional Names
- Short Name
- # tumors at Dx Cancer
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 2.16
- Last Updated
- Version 2.48
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
| 59852-4 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Número de tumores al diagnóstico: |
| it-IT | Italian (Italy) | Numero di tumori alla diagnosi: Synonyms: Cancro XXX Neoplasia maligna Numero (conta) Numero di tumori al momento della diagnosi Punto nel tempo (episodio) Registro tumori |
| ru-RU | Russian (Russian Federation) | Количество опухолей на [момент] диагноза: Synonyms: Количественный Количество Точка во времени; |
| zh-CN | Chinese (China) | 诊断时肿瘤的数量: Synonyms: NAACCR 肿瘤登记; |
Example Units
| Unit | Source |
|---|---|
| {#} | Example UCUM Units |
42033-1 Number of tumors and histologies
Term Description
This data item will clarify the number of simultaneous tumors (lesions) and the number of histologies for a given reported tumor. At a facility, this will reflect information for an individual abstract being prepared. At a central registry, this item can be consolidated to represent the best information obtained for a reportable tumor from multiple sources.
Information on the number of simultaneous tumors or lesions (per SEER multiple primary rules) would make it possible to more accurately consolidate source records and to facilitate the automation of this process.
.. NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Number of tumors & histologies
- Property
- Num
- Time
- Pt
- System
- ^Patient
- Scale
- Qn
- Method
Additional Names
- Short Name
- # tumors/hist
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 2.16
- Last Updated
- Version 2.48
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Número de tumores e histologías: |
| it-IT | Italian (Italy) | Numero di tumori & istologie: Synonyms: Numero (conta) Numero di tumori e istologie paziente Punto nel tempo (episodio) Registro tumori |
| pt-BR | Portuguese (Brazil) | Número de tumores e histologias: Synonyms: ; |
| ru-RU | Russian (Russian Federation) | Количество опухоль & гистологий: Synonyms: Количественный Количество Точка во времени; |
| zh-CN | Chinese (China) | 肿瘤和组织结构的数量: Synonyms: NAACCR 肿瘤登记; |
Example Units
| Unit | Source |
|---|---|
| {#} | Example UCUM Units |